7 Cambridge Center<br>Cambridge Massachusetts 02
320 Charles Street
About Broad InstituteThe Broad Institute was launched to pioneer a new model of collaborative biomedical science that would transform medicine. To accomplish these goals, we have built an amazing team of talented “Broadies” who work together to realize this transformation.
We are always looking for new Broadies to join our team and help us tackle important problems at the cutting edge of science.
The Broad community The Broad community includes professional scientists from many disciplines, administrative staff, and students. We seek to cultivate an interdisciplinary, goal-oriented work environment that unleashes scientific creativity and empowers our people to pursue ambitious and critical projects
Our work transcends traditional academic boundaries, giving Broad employees and affiliates access to an unparalleled biomedical research community across the Harvard and MIT communities and beyond.
Benefits of working at Broad The Broad Institute is committed to providing its employees with a competitive compensation and benefits package. We recognize the need for our employees to have a balance between work and personal life. To that end, our benefit plans and options reflect our desire to promote an environment that supports the health, diversity, and general wellbeing of our employees.
All Broadies also have access to world-class research and state of the art technology and are fully supported in their professional development, pushing the envelope for further growth.
The Broad Benefits Program includes:
• Medical • Dental • Basic Life Insurance, Accidental Death & Dismemberment, Business Travel and Supplemental Life Insurance • Short-Term and Long-Term Disability • Flexible Spending Accounts • 401(K) Plan w/Competitive Employer Match • 4 Weeks of Vacation after 1 Year • Tuition Reimbursement • Identity Theft Prevention and Insurance • Estate Planning • Adoption Assistance • Employee Assistance Program (EAP) • MBTA Commuter Transportation Subsidies • Parents in a Pinch Back Up Child Care • Credit Union
The Broad Institute is an equal opportunity employer.
To learn more about the Broad’s job opportunities, visit our Career Center at: https://www.broadinstitute.org/careers/career-center
124 articles with Broad Institute
11/12/2018Biopharma companies name new members of their leadership teams. Who made big moves this week?
Recently, 23andMe partnered with GlaxoSmithKline, causing the Forbes Technology Council to cite eight ways these types of partnerships will affect disease treatments. These types of partnerships aren’t exactly new.
10/15/2018Who mixed things up in the biotech world this past week? Pfizer announces its leadership team, Rheos gets a new COO, and board of directors updates from multiple biopharma companies.
It was a win for the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University, as a federal court of appeals ruled against the University of California (UC) on CRISPR patents.
CRISPR pioneer Jennifer Doudna has set up shop in San Francisco’s Gladstone Institutes. Doudna, a UC Berkley professor credited with the co-discovery of CRISPR-Cas9 genome editing technique, will focus on the development of new ways to implement the gene-editing technique for disease treatment.
RootPath, headquartered in Cambridge, Massachusetts, announced a $7 million seed funding round. The financing was led by Sequoia China. Volcanics Venture, BV (Baidu Ventures) and NestBio Ventures participated.
Cedilla Therapeutics Expands Leadership Team with New Appointments to Direct Biology, Drug Discovery and Proteomics
Cedilla Therapeutics today formally announced the appointment of three vice presidents with extensive experience in drug discovery to advance the company’s mission of harnessing existing protein stability mechanisms to redirect the course of disease.
Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.
Broad Institute Releases Open-Source GATK4 Software for Genome Analysis, Optimized for Speed and Scalability
Today the Broad Institute of MIT and Harvard is releasing version 4.0 of the Genome Analysis Toolkit, the institute's flagship genome variant discovery package for analysis of high-throughput sequencing data.
Syngenta Obtains Non-Exclusive IP License From Broad Institute for CRISPR-Cas9 Genome-Editing Technology for Agriculture Applications
CRISPR-Cas9 genome editing technology complements Syngenta’s already robust plant breeding innovation toolbox
Broad Institute And Deerfield Management Launch Innovative Partnership To Tackle Serious Unmet Medical Needs
Eisai Inc. Enters Into A New Joint Research Agreement With The Broad Institute To Develop An Antimalarial Medicine
Broad Institute To Release Genome Analysis Toolkit 4 (GATK4) As Open Source Resource To Accelerate Research
BGI To Work With Broad Institute, Intel And Alibaba Cloud To Provide Free Access To GATK4 On BGI Online Platform
Cohen Veterans Bioscience And The Broad Institute's Stanley Center For Psychiatric Research With PTSD Researchers From The Psychiatric Genomics Consortium Announce Initial Findings From Largest Study Of Genetic Markers For Post-Traumatic Stress Disorder
AmpliPhi Bio Establishes Scientific Advisory Board And Appoints Dr. Timothy Lu Of MIT And Broad Institute As SAB Chairman
Monsanto Announces Global Genome-Editing Licensing Agreement With Broad Institute For Newly-Characterized CRISPR System